How Medical Marijuana Can Help With ALS (Or Lou Gehrig's Disease)

This article was originally published on The Fresh Toast, and appears here with permission.

Hundreds of studies have looked into the benefits of THC and CBD on pain and overall health, and in the last decade alone, dozens have focused on the effect of cannabinoids on ALS. 

One of the most widely misunderstood disorders, amyotrophic lateral sclerosis (ALS,) seems to make headlines for the beautiful lives it has taken, including famous baseball legend Lou Gehrig. 

As a progressive neurodegenerative disease, ALS causes patients to lose control of bodily functions such as eating, speaking, and breathing, creating heartache for those who battle the disease. An estimated 30,000 Americans are living with ALS, with 5,000 individuals diagnosed per year, according to the ALS Association. A humbling statistic also is present with ALS, as it was found in a study that veterans are two-times more likely to be diagnosed with ALS over the general public. 

Hundreds of studies have looked into the benefits of THC and CBD on pain and overall health, and in the last decade alone, dozens have focused on the effect of cannabinoids on ALS

RELATED: Cannabis And Lou Gehrig’s Disease: Here’s What You Should Know

Photo by Bru-nO via Pixabay

  • Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
  • Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
  • Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Share Price: $0.80
Min. Investment: $1,000
Valuation: $3.5B

Here are two promising studies about THC and CBD’s effects on those battling ALS: 

  •  Cannabis and amyotrophic lateral sclerosis: The US National Library of Medicine National Institutes of Health summarized, “Preclinical data indicate that cannabis has powerful antioxidative, anti-inflammatory, and neuroprotective effects,” when it was added to ALS therapies. 
  •  Neurological aspects of medical use of CBD: The US National Library of Medicine National Institutes of Health found that “Pre-clinical evidence largely shows that CBD can produce beneficial effects in MS patients.” 

While on-going, studies continue to show promise for ALS. The Neural Regeneration Research Journal recently published a piece on ALS and cannabis. ALSToday shares:

“According to a single observational study of patients with ALS, only the 10 percent who admitted consuming cannabis revealed moderate relief of several symptoms, including appetite loss, depression, pain and drooling.” 

While ultimately research is focused on eliminating ALS altogether, for those suffering and caregivers watching, CBD and cannabinoids may help ease symptoms for a better quality of life.

By The Fresh Toast's Kate-Madonna Hindes, provided exclusively to Benzinga Cannabis.

Continue reading:

Market News and Data brought to you by Benzinga APIs

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!

Comments
Loading...